Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

Blood - United States
doi 10.1182/blood.v126.23.610.610
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Genetic Deletions in AML and MDS

Best Practice and Research in Clinical Haematology
OncologyClinical Biochemistry
2010English

From MDS/AML to iPSC and Back Again

Science Translational Medicine
Medicine
2017English

Molecular Characterization of Chromosome 7 in AML and MDS Patients

African Journal of Health Sciences
2008English

Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML

Frontiers in Pharmacology
Pharmacology
2018English

Translocation T(1;3)(p36;p21) and Other Aberrations in a Case of AML Secondary to MDS

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2014English

Physicians Poster Session: Acute Leukemia and Secondary AML/MDS

Bone Marrow Transplantation
TransplantationHematology
2003English

Transformation of MDS/MPN-RS-T to AML: Trisomy 13, Resistant Thrombocytosis and Transient Disease Control With Oral Busulfan Therapy

American Journal of Hematology
Hematology
2017English

Longitudinal Changes in Depressive Circuitry in Response to Neuromodulation Therapy

Frontiers in Neural Circuits
Molecular NeuroscienceSensory SystemsNeuroscienceCellularCognitive Neuroscience
2016English

WT1 Vaccination in AML and MDS: A Pilot Trial With Synthetic Analog Peptides

American Journal of Hematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy